Cancer, Ovarian Terminated Phase 2 Trials for Sorafenib (DB00398)

Also known as: Cancer of the Ovary / Ovarian Cancer / Ovary Cancer / Cancer of Ovary / Ca ovary / Malignant tumor of ovary / Malignant neoplasm of ovary / Ovarian cancer NOS

DBCOND0063542 (Cancer, Ovarian)Terminated2 IdentifierTitlePurposeDrugs
NCT00522301Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second RemissionTreatment